(Q41884137)

13 October 2017

Influence of immune inflammation on androgen receptor expression in benign prostatic hyperplasia tissue (English)

1 reference

13 October 2017

prostatic hypertrophy

1 reference

Zong-Lin Wu

1

1 reference

13 October 2017

Ya Yuan

series ordinal

2

1 reference

13 October 2017

He Geng

series ordinal

3

1 reference

13 October 2017

Shu-Jie Xia

series ordinal

4

1 reference

13 October 2017

12 December 2011

1 reference

Asian Journal of Andrology

13 October 2017

1 reference

13 October 2017

14

1 reference

13 October 2017

2

1 reference

13 October 2017

316-319

1 reference

Etiology, epidemiology, and natural history of benign prostatic hyperplasia

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Proliferation and phenotypic changes of stromal cells in response to varying estrogen/androgen levels in castrated rats

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Mechanism of androgen receptor action

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

5alpha-reductase isozymes and androgen actions in the prostate

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Growth factors in benign prostatic hyperplasia: basic science implications

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Prostate growth and inflammation.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Inflammation and chronic prostatic diseases: evidence for a link?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Could inflammation be a key component in the progression of benign prostatic hyperplasia?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Characteristic pattern of human prostatic growth with age.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Apoptosis and hormonal milieu in ductal system of normal prostate and benign prostatic hyperplasia

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3735085

Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia

18 August 2018

1 reference

12 December 2020

Androgen receptor isoforms in human and rat prostate

1 reference

12 December 2020

Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation

1 reference

12 December 2020

Distribution of Inflammation, Pre-Malignant Lesions, Incidental Carcinoma in Histologically Confirmed Benign Prostatic Hyperplasia: A Retrospective Analysis

1 reference

12 December 2020

The development of human benign prostatic hyperplasia with age

1 reference

12 December 2020

Pathology of benign prostatic hyperplasia

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJA.2011.154

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

22157983

1 reference